超声乳化白内障吸除术对糖尿病白内障角膜内皮细胞影响的研究  

Research progress on effect of phacoemulsification on corneal endothelial cells in patients with diabetic cataract

作　　者：黄菊 李诗怡 张澳 王康[1] 张培培[1] 谢迎宾[1] Huang Ju;Li Shiyi;Zhang Ao;Wang Kang;Zhang Peipei;Xie Yingbin(Department of Ophthalmology,Binzhou Medical University Hospital,Binzhou 256603,China)

机构地区：[1]滨州医学院附属医院眼科,滨州256603

出　　处：《国际医药卫生导报》2024年第21期3558-3564,共7页International Medicine and Health Guidance News

基　　金：山东省医药卫生科技发展计划(2014WS0200);滨州医学院科技计划(BY2020KJ05)。

摘　　要：糖尿病性白内障是造成糖尿病患者视力下降和失明的主要原因。超声乳化白内障吸除术(Phaco)是临床治疗白内障的常见手段。糖尿病和Phaco是导致角膜内皮细胞损伤的危险因素,通过保护糖尿病患者术前、术中与术后的角膜内皮细胞,可有效减轻Phaco对角膜内皮细胞的损害。本文综述糖尿病和Phaco对角膜内皮细胞的影响及可能机制,以及在Phaco术前、术中与术后对糖尿病患者角膜内皮细胞的保护措施。Diabetic cataract is one of the leading causes of vision loss and blindness in diabetic patients.Phacoemulsification is a common clinical treatment for cataracts.Both diabetes and phacoemulsification are risk factors for corneal endothelial cell damage.Corneal endothelial cell damage by phacoemulsification can be effectively mitigated by protecting corneal endothelial cells in diabetic patients before,during,and after surgery.This article reviews the effects and possible mechanisms of diabetes and phacoemulsification on corneal endothelial cells,as well as measures to protect corneal endothelial cells in diabetic patients before,during,and after phacoemulsification.

关 键 词：超声乳化白内障吸除术 糖尿病 白内障 角膜内皮细胞 进展 

分 类 号：R779.66[医药卫生—眼科]